Allele Biotechnology

Allele Biotechnology and Pharmaceuticals, Inc. explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development. Their mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms.

Allele utilizes proprietary non-integrating cellular reprogramming methods to enable drug discovery and cell therapy, including human and non-human primate iPS cells, GMP-grade human iPS cells and their derivatives, and differentiated cell types. With additional expertise in genome modification and cell-based sensors/reporters, Allele provides advanced cell and assay development solutions. They also have developed a wide variety of reagents including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies. Allele has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.

Bio-Connect supplies all Allele Biotechnology products in the Benelux. If you have any questions, please contact the helpdesk.

Major product lines

  • Fluorescent proteins
  • iPS stem cells
  • nAb - Nano antibodies
  • Viral expression systems
  • Protein analysis
  • Tissue culture cell assays

Allele Biotechnology news

For more information, please visit: